If you have any question, please feel free to email us. We will touch with you as soon as possible.
CAS:4618-18-2
Source:Europe
Qualifications:/-/-/-/-
Name | Lactulose solution |
---|---|
Chinese name | 乳果糖溶液 |
Cas Number | 4618-18-2 |
Source | Europe |
Qualifications | /-/-/-/- |
Lactulose is a prescription drug used to treat hepatic encephalopathy and constipation. More than 100 countries have included it in the pharmacopoeia category, and it has been included in the "World Health Organization Model List of Essential Medicines" (World Health Organization Model List of Essential Medicines) , Is one of the important drugs necessary for the basic health system of the human body. A randomized-double-blind-controlled clinical trial study showed that in the treatment of hepatic encephalopathy with obvious symptoms, the combination of rifaximin and lactulose can achieve better clinical effects than rifaximin alone: it is effective Reverse the symptoms of patients, shorten the length of hospital stay, and reduce the mortality of patients due to sepsis. There are also studies on bowel cleansing preparations before colonoscopy that lactulose oral liquid has better efficacy in bowel preparations than compound polyethylene glycol electrolyte powder. Since the launch of lactulose oral solution in 2014, sales in the drugstore terminal and the third medical terminal have shown a soaring trend, and have achieved a good market share. In 2019, the Chinese domestic market capacity of lactulose oral solution is about 30 million bottles/year.
Hot Tags: lactulose solution api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Lifitegrast API, Troxagliptin Succinate API, Itraconazole Hydrochloride API, Apremilast API, Pleasant API, Pabxilib API
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China